Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
Researchers from Massachusetts Institute of Technology report on findings in vaccines
September 9th, 2008
Researchers detail in 'Injectable dendritic cell-carrying alginate gels for immunization and immunotherapy,' new data in vaccines. "Dendritic cell vaccines, in which antigen-loaded dendritic cells (DCs) are injected directly into patients to trigger immune responses, are in development as a treatment for cancer and some infectious diseases. In this study, we tested the concept of delivering DCs in an injectable hydrogel matrix, with the aim of harboring dendritic cells for prolonged time periods at a defined site and trapping/concentrating factors secreted by DCs to establish an inflammatory milieu in situ," scientists in the United States report. "To achieve these...
Source: Cancer Weekly (2008-09-09)
|
